Financial News

Novo Nordisk shares plunge 10% after Alzheimer’s drug trial fails to hit key target

Novo Nordisk shares plunge 10% after Alzheimer’s drug trial fails to hit key target

by
News PRO
November 24, 2025

Shares of Novo Nordisk on Monday fell 10% after the Danish drug pharmaceutical company said a highly-anticipated trial for Alzheimer’s disease failed to meet its main goal.Read More

Related

Related Topics

More in Financial News

We’re buying more shares of this cybersecurity giant after a tough post-earnings stretch

The stock has tumbled since the company reported earnings last Wednesday evening, despite a clean beat...
Gap CEO says viral Katseye ad boosted sales despite tariffs turmoil

Gap Inc. CEO Richard Dickson told CBS News’ Jo Ling Kent that he feels...
It’s Thanksgiving week. These are expected to be the busiest travel days.

It’s a busy week for millions of Americans who are traveling for Thanksgiving.At the...
Kohl’s names fourth CEO in four years as it seeks to move past leadership turmoil

Kohl’s on Monday said it has tapped its fourth CEO in as many years,...

6 airlines cancel flights in Venezuela after FAA warns of dangers from “heightened military activity”

Many retirees soon must take year-end required withdrawals — and mistakes can be costly